Abstract: Podocarpamide, isolated from the bark of Zanthoxylum podocarpum Hemsl., is a new compound with platelet aggregation inhibiting and SGPT level lowering activities. Its structure was inferred to have two possible forms, either Ⅰ or Ⅱ, from its spectra. The structure of podocarpamide was identified as Ⅰ by synthesis.